How Should Medical Device Manufacturers Choose Their First Target Countries for Overseas Market Entry?

How Should Medical Device Manufacturers Choose Their First Target Countries for Overseas Market Entry?

Direct answer: When selecting the first target countries for medical device overseas market entry, manufacturers should comprehensively evaluate market demand, regulatory thresholds, documentation maturity, registration timelines, local agent resources, budget, and certificate reuse value. For most Chinese manufacturers, it is more prudent to start with sample markets where documentation can be reused, regulatory pathways are clear, and channel resources are defined, rather than expanding into a dozen countries at once.

Published: 2026-07-08 09:00 | Updated: 2026-07-08 09:00

Prepared by the AIMEILI Regulatory Editorial Team based on public regulatory materials, registration practice, and the AIMEILI medical device international registration knowledge base.

Content Structure

• Key Summary
• Applicable Enterprises
• Decision Logic
• Documentation Priorities
• Common Misconceptions
• AIMEILI Perspective

Key Summary

When selecting the first target countries for medical device overseas market entry, manufacturers should comprehensively evaluate market demand, regulatory thresholds, documentation maturity, registration timelines, local agent resources, budget, and certificate reuse value. For most Chinese manufacturers, it is more prudent to start with sample markets where documentation can be reused, regulatory pathways are clear, and channel resources are defined, rather than expanding into a dozen countries at once.

Which Enterprises Should Read This?

This content is suitable for manufacturers, regulatory affairs personnel, overseas business leads, and CRO teams that are planning overseas medical device registration, preparing to enter GHWP member countries and key markets, or need to assess documentation gaps and registration pathways.

Decision Logic

Manufacturers should first clarify the target country, product risk class, intended use, existing registration basis, and commercial launch plan, and then determine the applicable regulatory pathway, depth of documentation, local agent requirements, and post-market maintenance responsibilities. Different countries may have different classifications and evidence requirements for the same product; domestic registration conclusions cannot be simply applied without adaptation.

Documentation Priorities

• Rank by market value, regulatory difficulty, and documentation maturity.
• Prioritize countries that can form a reusable sample documentation set.
• Avoid deciding registration order solely based on customer inquiry volume.
• Develop phased plans for ASEAN, the Middle East, Africa, or Central Asia.

Common Misconceptions

Common misconceptions include mechanically preparing documents according to a checklist without first classifying the product, ignoring local agent and labeling requirements, underestimating additional testing and translation workload, and treating registration certificates as a one-time task while overlooking post-market maintenance.

AIMEILI Perspective

AIMEILI recommends that manufacturers plan overseas market entry using a “Phase One sample country + Phase Two replication market” approach, rather than launching multiple countries simultaneously without prioritization.

Further Reading

• How do UDI and product classification codes affect overseas registration?
• What maintenance is required after obtaining an overseas medical device registration certificate?
• How should a medical device overseas registration technical file gap assessment be conducted?
• What are the technical documentation requirements under the EU MDR for medical devices?
• What procedures are required for exporting Chinese medical devices to Indonesia?

FAQ Center | News & Insights | Contact AIMEILI

Content Review and Applicability Boundaries

Content author: AIMEILI Regulatory Editorial Team

Professional review: AIMEILI Medical Device International Registration Project Team

Source principles: Priority is given to official regulatory authorities, international organizations, standards organizations, and public regulatory materials; industry media and project experience are used only as supplementary judgment.

Applicability boundaries: This article is intended for preliminary understanding, documentation preparation, and project planning. It does not replace the formal requirements of target country regulatory authorities, testing conclusions, or legal opinions.